The primary objective of this non-interventional study is to investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia. This will be done by a retrospective review of medical records to evaluate patients treated with Seroquel XR or Seroquel IR as primary antipsychotic treatment.
Study Type
OBSERVATIONAL
Enrollment
300
Research Site
Falköping, Sweden
Research Site
Gothenburg, Sweden
Research Site
Helsingborg, Sweden
Research Site
To investigate how Seroquel XR and Seroquel IR are used in the clinical practice of inpatients with schizophrenia
Time frame: every day for the time period of 15 Oct to 31 Dec 2010
To investigate comorbidities of patients with schizophrenia receiving Seroquel XR and IR
Time frame: every day for the time period of 15 Oct to 31 Dec 2010
To investigate whether Seroquel XR and Seroquel IR are used to treat different types of inpatients with schizophrenia by evaluation of patient characteristics
Time frame: every day for the time period of 15 Oct to 31 Dec 2010
To investigate the treatment sequence of Seroquel XR and Seroquel IR in the clinical practice of patients with schizophrenia by evaluation of duration, dosage, reason for treatment, and, if applicable, reason for change, with Seroquel XR and Seroquel IR
Time frame: every day for the time period of 15 Oct to 31 Dec 2010
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Karlskrona, Sweden
Research Site
Karlstad, Sweden
Research Site
Lund, Sweden
Research Site
Malmö, Sweden
Research Site
Mölndal, Sweden
Research Site
Öjebyn, Sweden
Research Site
Stockholm, Sweden
...and 4 more locations